This paper compares health care systems. It looks beyond normal academic, political, or journalistic rhetoric, by exactly sticking to facts, i.e. empirical data (in particular data provided by the WHO) and comprehensive case study analyses. The paper finds that a number of myths and common...

We examine the persistence of the association between subjective health assessments of both first and second-generation migrants with that of their country of origin. To mitigate potential selection bias, we use European data containing records from 30 countries, including over 90 countries of...

Past research has provided evidence of the role of some personal characteristics as risk factors for depression. However, few studies have examined jointly their specific impact and whether country characteristics change the probability of being depressed. In general, this is due to the use of...

Judge Bryson recently asserted in Association for Molecular Pathology v. US Patent and Trademark Office (dissenting-in-part) that human gene patents "present a significant obstacle to the next generation of innovation in genetic medicine — multiplex tests and whole-genome sequencing." His...

Patents are often portrayed as the necessary reward to compensate pharmaceutical firms for the huge costs and risks associated with Food and Drug Administration (FDA)-mandated clinical trials of new drugs. But the relationship between the patent system and other regulation of drugs is more...